Professional Documents
Culture Documents
Chemical Peels in Active Acne PDF
Chemical Peels in Active Acne PDF
Chemical Peels in Active Acne and Acne Scars
PII: S0738-081X(16)30272-3
DOI: doi: 10.1016/j.clindermatol.2016.10.011
Reference: CID 7109
Please cite this article as: Kontochristopoulos Georgios, Platsidaki Eftychia, Chem-
ical Peels in Active Acne and Acne Scars, Clinics in Dermatology (2016), doi:
10.1016/j.clindermatol.2016.10.011
This is a PDF file of an unedited manuscript that has been accepted for publication.
As a service to our customers we are providing this early version of the manuscript.
The manuscript will undergo copyediting, typesetting, and review of the resulting proof
before it is published in its final form. Please note that during the production process
errors may be discovered which could affect the content, and all legal disclaimers that
apply to the journal pertain.
ACCEPTED MANUSCRIPT
1
P T
RI
Corresponding author:
Eftychia Platsidaki
SC
5 Ionos dragoumi Street, Athens, Greece, 16121
NU
platsidakieft@yahoo.com MA
Abstract
pyruvic acid (PA), lactic acid (LA), mandelic acid (MA), Jessner's solution
(JS), trichloroacetic acid (TCA), and phenol. Choosing the appropriate peel is
CE
based on patient’s skin type, the acne activity and the type of acne scars.
Combination peels minimize side effects. In acne scars, chemical peels may
be combined with other procedures in order to achieve better clinical results.
AC
Introduction
Acne has a prevalence of over 90% in the adolescent community and persists
into adulthood in approximately 12%–14% of patients1. Follicular
hyperkeratinization, increased sebum production, proliferation of
Propionibacterium acnes within the follicle and release of inflammatory
mediators into the skin contribute to the development of acne2.
Possible outcomes of the inflammatory acne lesions are acne scars which can
have a considerable emotional and psychologic distress. Minor acne scarring
may occur in up to 95% of patients and to a significant degree in only 22%. 3
They represent areas of fibrous tissue that replace normal skin following
injury.
ACCEPTED MANUSCRIPT
2
1. inflammatory
2. proliferative
3. matrix remodeling.
T
During the proliferative phase mainly type III collagen is produced, with much
P
smaller percentage of type I collagen. In mature scars the balance of collagen
types shifts to approximately 80% of type I collagen. 4 Matrix
RI
metalloproteinases (MMPs) and tissue inhibitors of matrix metalloproteinases
SC
(TIMPs) are then produced. Decreased ratio of MMPs to TIMPs results in the
development of atrophic scars4. Atrophic scars have been subclassified into
ice pick, boxcar, and rolling scars. Sometimes, all these types of scars can be
NU
observed in the same patient.
When combination peels are used, better clinical results can be achieved with
reduced risk of complications. In active acne and acne scars the above
mentioned peeling agents reduce sebum production, exert a comedolytic
effect, cause keratolysis and possess anti-inflammatory and antibacterial
properties. (Table1). In active acne they can be either performed
supplementary to classic treatment, because they promote the effect of topical
agents or provide maintenance therapy. In addition, in acne scars, they can
be used in combination with other resurfacing procedures.
ACCEPTED MANUSCRIPT
3
Salicylic acid (SA) is a beta-hydroxy acid. It is the peeling agent of choice for
active acne due to its strong comedolytic and sebostatic effect.6-8 SA has the
ability to dissolve intercellular cement thereby reducing corneocyte adhesion.
Used in multiple sessions it reduces the number of inflammatory and non-
T
inflammatory acne lesions, while erythema, dryness, and burning sensation
P
have been the most common side effects.5 The efficacious concentration for
acne scars is 30%, repeated every 3-4 weeks for a total of 3-5 sessions.4 In
RI
patients with ethnic skin, SA remains an excellent superficial peeling agent ,as
SC
the others have been associated with post-inflammatory pigment alteration. It
has the ability for self-neutralization with a very good safety profile. In a recent
study, oral isotretinoin combined with 20% SA peels at a 2 weekly interval in
NU
patients with active acne showed better results compared with isotretinoin
monotherapy.6 Another benefit of SA is its lightening effect on post-
inflammatory pigmentation due to acne.9
MA
Glycolic acid (GA) is an alpha-hydroxy acid ,which decreases corneocyte
cohesion and promotes desquamation and epidermolysis. Due to its
exfoliative properties, it is widely used as a superficial peeling agent.10 In
ED
Though acne improved in both to the same extent, there was more exfoliation
seen in the Jessner’s Solution group.14
AC
In acne scars, glycolic acid increases dermal hyaluronic acid and collagen
gene expression by increasing secretion of IL-6.15 Glycolic acid, in the
concentration of 10-30% for 3-5 minutes at fortnightly intervals, revealed that
the treatment is quite effective and safe in the management of superficial
scarring.16 In another study, glycolic acid peels were compared versus
salicylic-mandelic acid combination peels (SMPs) in active acne vulgaris and
post-acne scarring. Both agents were effective and safe with SMPs
demonstrating higher efficacy.17 Combination of microneedling and glycolic
acid peels had a significant improvement in acne scars.18 General
contraindications include contact dermatitis, pregnancy, and glycolate
hypersensitivity. Side effects, such as temporary hyperpigmentation or
irritation, are not significant, and it is generally considered as a well-tolerated
procedure.19
Lactic acid (LA) is a weak a-hydroxy acid, which reduces the thickness of the
T
stratum corneum by decreasing corneocyte cohesion.22 It has skin lightening
P
and moisturizing effect. A pilot study, using full strength 92% pure lactic acid
RI
peel to improve superficial acne scarring, showed a definite improvement in
the texture, pigmentation, and appearance of the treated skin, with lightening
of scars.23
SC
Mandelic acid (MA) is another a-hydroxy acid. As its molecule is large, skin
penetration is slow and is considered as a safe superficial peeling agent. It
NU
has been used at 20-50% concentrations for skin rejuvenation and lightening.
A combination of 20% salicylic acid peel and 10% mandelic (SMP) has been
proven effective in acne vulgaris and post-acne scarring.17
MA
Jessner's Solution (JS) consists of 14% salicylic acid, 14% resorcinol or
citric acid, and 14% lactic acid in 95% ethanol and is used as a superficial
peeling agent. In a recent study,there wasmarked diminution of acne scars
ED
was seen in patients treated with 20% TCA and Jessner's solution versus
20% TCA alone.24It is contraindicated in active inflammation, dermatitis, or
infection of the area to be treated.
PT
Trichloroacetic acid (TCA) is the gold standard in chemical peels, which can
be used either as a superficial, medium depth, or deep peel, depending on the
CE
The advantages of TCA are low cost and the fact that penetration can be
easily evaluated by the color of frost.27 Combining TCA peel with other
procedures have been previously described in acne scars’ treatment. A study
Combining non-ablative fractional laser and 20% TCA peel had better results
than each individual modality in the treatment of atrophic acne scars.28
Another group found that deep peeling, using phenol and 20% TCA peeling,
was effective in treating post-acne atrophic scars.29
ACCEPTED MANUSCRIPT
5
A new technique has been proposed, using focal application of TCA, called
CROSS (chemical reconstruction of skin scars) method.30 TCA CROSS
technique is the use of high concentrations TCA (50-100%) applied with
wooden applicators to isolated atrophic acne scars. It is applied for a few
T
seconds until a white frosting appears within the scar. This has shown high
P
efficacy and additionally reduces the risk of hypopigmentation by sparing the
adjacent normal skin and adnexal structures.31The procedure can be repeated
RI
at 4-week intervals up to a total of three treatments. TCA CROSS technique
is particularly useful for icepick scarring.32-33 A pilot study evaluated the safety
SC
of the TCA CROSS technique using 100% TCA among Asians with darker
skin types ,and all patients had good to excellent results,34 while a larger study
NU
was conducted using the same method with excellent results achieved in
more than 70% of patients.35 An additional study evaluated the efficacy and
safety of intradermal injection of Platelet-rich plasma (PRP), 100% focal TCA,
MA
and combined skin needling plus topical PRP in the treatment of atrophic
acne scars, and all patients showed highly significant improvement in acne
scars.36
ED
The selection of the appropriate peel depends on patients skin type, the acne
activity, and the type of acne scars (Table 2). This ensures better results and
minimizes complications. In active acne the treatment goal is reduction of
inflammation, quick decrease in lesional count, and improvement of overall
skin texture. Superficial peels are used in comedonal and papulopustular
acne. 20-30% SA, 70% GA, 40-60% PA, 20-25% MA, JS, 10%TCA are
preferred.3,4,28 In nodulocystic acne, superficial peels are not indicated.
The best results are achieved in macular scars. Superficial peelings, including
30% SA, 20-70% GA, 92% LA, JS and 10-25% TCA, as well as medium depth
peelings including 40-60% PA, 25-50% TCA, and combined peelings, such as
25% SA + 25-30% TCA, JS + 35% TCA, SMP, are m recommended for
superficial acne scars.3,39
For deep scars, deep peelings have been proven to be effective. Those
commonly used are TCA at concentrations over 40%, TCA CROSS method,
ACCEPTED MANUSCRIPT
6
T
Chemical peels and isotretinoin
P
In the past, peels, lasers, and dermabrasion have been associated with
RI
hypertrophic scars and keloid when used during or soon after completion of
isotretinoin treatment. The mechanism is unknown. A possible explanation
SC
was through increased penetration of the chemical agent, induction of
angiogenesis, and synthesis of inhibitors of collagenase. 43 The European
evidence-based (S3) guidelines for the treatment of acne recommend acne
NU
scar repair procedures to be avoided within 6 months post isotretinoin
treatment;44 however, there are small studies, suggesting that isotretinoin is
not an absolute contraindication for peeling.6,45-46 Until further evidence
MA
emerges, we recommend avoiding chemical peels for at least 6 months after
cessation of isotretinoin.
ED
Conclusions
Chemical peels are very useful in the treatment of acne, targeting multiple
PT
an effective treatment for deep acne scars, where medium depth peels and
TCA CROSS method are preferred. Caution is needed when medium and
deep peels are used in dark skinned patients due to the risk of pigmentary
AC
References
4. Fabbrocini, G., Annunziata, M.C., D'Arco, V., De Vita, V., Lodi, G.,
Mauriello, M.C., Pastore, F., Monfrecola, G. Acne Scars: Pathogenesis,
Classification and Treatment. Dermatol Res Pract. 2010;2010:893080.
5. Lee, H.S., Kim, I.H. Salicylic acid peels for the treatment of acne
vulgaris in Asian patients. Dermatol Surg. 2003;29:1196–1199.
T
6. Kar, B.R., Tripathy, S., Panda, M. Comparative Study of Oral
Isotretinoin versus Oral Isotretinoin +20% Salicylic Acid Peel in the
P
Treatment of Active Acne. J Cutan Aesthet Surg. 2013;6:204-208.
RI
7. Kligman, D., Kligman, A.M. Salicylic acid as a peeling agent for the
treatment of acne. Cosmetic Dermatol. 1997;10:44–47.
SC
8. Lai, K.W., Mercurio, M.G. Update on the treatment of acne vulgaris. J
Clin Outcomes Manag. 2009;16:115–126.
9. Ahn, H.H., Kim, I.H. Whitening effect of salicylic acid peels in Asian
NU
patients. Dermatol Surg. 2006;32:372–375.
10. Kessler, E., Flanagan, K., Chia, C., Rogers, C., Glaser, D.A.
Comparison of alpha- and beta-hydroxy acid chemical peels in the
MA
treatment of mild to moderately severe facial acne vulgaris. Dermatol
Surg. 2008;34:45–50.
11. Takenaka, Y., Hayashi, N., Takeda, M., Ashikaga, S., Kawashima, M.
Glycolic acid chemical peeling improves inflammatory acne eruptions
ED
12. Atzori, L., Brundu, M.A., Orru, A., Biggio, P. Glycolic acid peeling in the
treatment of acne. J Eur Acad Dermatol Venereol. 1999;12:119-122.
13. Dréno, B., Fischer, T.C, Perosino, E., Poli, F., Viera, M.S., Rendon,
CE
2011;25:695–704.
14. Kim, S.W., Moon, S.E., Kim, J.A., Eun, H.C. Glycolic acid versus
Jessner’s solution: which is better for facial acne patients? A
randomized prospective clinical trial of split-face model therapy.
Dermatol Surg. 1999;25:270–273.
15. Bernstein, E.F., Lee, J., Brown, D.B., Yu, R., Van Scott, E. Glycolic
acid treatment increases type I collagen mRNA and hyaluronic acid
content of human skin. Dermatologic Surgery. 2001;27:429–433.
16. Grover, C., Reddu, B.S. The therapeutic value of glycolic acid peels in
dermatology. Indian J Dermatol Venereol Leprol. 2003;69:148-150.
17. Garg, V.K., Sinha, S., Sarkar, R. Glycolic acid peels versus salicylic-
mandelic acid peels in active acne vulgaris and post-acne scarring and
hyperpigmentation: a comparative study. Dermatol Surg. 2009;35:59-
65.
ACCEPTED MANUSCRIPT
8
18. Sharad, J. Combination of microneedling and glycolic acid peels for the
treatment of acne scars in dark skin. J Cosmet Dermatol. 2011;10:317-
323.
19. Javaheri, S.M., Handa, S., Kaur, I., Kumar, B. Safety and efficacy of
glycolic acid facial peel in Indian women with melasma. International
T
Journal of Dermatology. 2001;40:354–357.
20. Van Scott, E.J., Yu, R.J. Alpha hydroxy acids: therapeutic potentials.
P
Canadian Journal of Dermatology. 1989;1:108–112.
RI
21. Berardesca, E., Cameli, N., Primavera, G., Carrera, M. Clinical and
instrumental evaluation of skin improvement after treatment with a new
SC
50% pyruvic acid peel. Dermatologic Surgery. 2006;32:526–531.
22. Bennett, L., Henderson Jr, R.L. Introduction to cosmetic dermatology.
Curr Probl Dermatol. 2003;15:43–83.
NU
23. Sachdeva, S. Lactic acid peeling in superficial acne scarring in Indian
skin. J Cosmet Dermatol. 2010;9:246–248.
24. Puri, N. Efficacy of modified Jessner's peel and 20% TCA versus 20%
MA
TCA peel alone for the treatment of acne scars. J Cutan Aesthet Surg.
2015;8:42-45.
25. Dinner, M.I., Artz, J.S. The art of the trichloroacetic acid chemical peel.
Clinics in Plastic Surgery. 1998;25:53–62.
ED
2002;28:383-387.
27. Gozali, M.V., Zhou, B. Effective treatments of atrophic acne scars. J
Clin Aesthet Dermatol. 2015;8:33-40.
CE
28. Leheta, T.M. Role of the 585-nm pulsed dye laser in the treatment of
acne in comparison with other topical therapeutic modalities. J Cosmet
Laser Ther. 2009;11:118-124.
AC
29. Leheta, T.M., Abdel Hay, R.M., El Garem, Y.F. Deep peeling using
phenol versus percutaneous collagen induction combined with
trichloroacetic acid 20% in atrophic post-acne scars; a randomized
controlled trial. J Dermatolog Treat. 2014;25:130-136.
30. Lee, J.B., Chung, W.G., Kwahck, H., Lee, K.H. Focal treatment of acne
scars with trichloroacetic acid: chemical reconstruction of skin scars
method. Dermatol Surg. 2002;28:1017-1021.
31. Yug, A., Lane, J.E., Howard, M.S., Kent, D.E. Histological study of
depressed acne scars treated with serial high concentration (95%)
trichloroacetic acid. Dermatol Surg. 2006;32:985–990.
32. Kitano, Y., Uchidda, H. Analysis of focal high concentration TCA
treatment for atrophic acne scarring. Jap J Plast ReconstrSurg.
2006;49:573–653.
33. Slavin, J.W. Trichloroacetic acid peels. Aesthetic Surgery Journal.
2004;24:469–470.
ACCEPTED MANUSCRIPT
9
T
darker skin types. J Cosmet Dermatol. 2011;10:51–57.
36. Nofal, E., Helmy, A., Nofal, A., Alakad, R., Nasr, M. Platelet-rich
P
plasma versus CROSS technique with 100% trichloroacetic acid versus
RI
combined skin needling and platelet rich plasma in the treatment of
atrophic acne scars: a comparative study. Dermatol Surg.
SC
2014;40:864-873.
37. Deprez, P. Textbook of chemical peels: Superficial, medium and deep
peels in cosmetic practice. London: Informa Healthcare; 2007:206.
NU
38. Park, J.H., Choi, Y.D., Kim, S.W., Kim, Y.C., Park, S.W. Effectiveness
of modified phenol peel (Exoderm) on facial wrinkles, acne scars and
other skin problems of Asian patients. J Dermatol. 2007;34:17-24.
MA
39. Zakopoulou, N., Kontochristopoulos, G. Superficial chemical peels. J
Cosmet Dermatol. 2006;5:246-253.
40. Lee, J.B., Chung, W.G., Kwahck, H., Lee, K.H. Focal treatment of acne
scars with trichloroacetic acid: chemical reconstruction of skin scars
ED
44. Nast, A., Dréno, B., Bettoli, V., Degitz, K., Erdmann, R., et al. European
evidence-based (S3) guidelines for the treatment of acne. J Eur Acad
Dermatol Venereol. 2012;26 Suppl 1;1-29.
45. Picosse, F.R., Yarak, S., Cabral, N.C., Bagatin, E. Early chemabrasion
for acne scars after treatment with oral isotretinoin. Dermatol Surg.
2012;38:1521-1526.
46. Bagatin, E., dos Santos Guadanhim, L.R., Yarak, S., Kamamoto, C.S.,
de Almeida, F.A. Dermabrasion for acne scars during treatment with
oral isotretinoin. Dermatol Surg. 2010;36:483-489.
ACCEPTED MANUSCRIPT
10
P T
RI
SC
NU
MA
Table 1: Mechanism of action of various peeling agents in acne
ED
PT
CE
AC